Advertisement
Screener

Amgen Inc. (AMGN) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

Amgen Inc. Shares Authorized

Amgen Inc. (AMGN) had Shares Authorized of 2.75 billion shares as of 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-05

  • 2026-06-30: Common Stock, Shares Authorized 2.75B shares.
  • 2026-03-31: Common Stock, Shares Authorized 2.75B shares.
  • 2025-12-31: Common Stock, Shares Authorized 2.75B shares.
  • 2025-09-30: Common Stock, Shares Authorized 2.75B shares.
Period endCommon Stock, Shares Authorized
2026-06-302.75B shares
10-Q · filed 2026-08-05
2026-03-312.75B shares
10-Q · filed 2026-05-01
2025-12-312.75B shares
10-Q · filed 2026-08-05
2025-09-302.75B shares
10-Q · filed 2025-11-05
2025-06-302.75B shares
10-Q · filed 2025-08-06
2025-03-312.75B shares
10-Q · filed 2025-05-02
2024-12-312.75B shares
10-K · filed 2026-02-13
2024-09-302.75B shares
10-Q · filed 2024-10-31
2024-06-302.75B shares
10-Q · filed 2024-08-07
2024-03-312.75B shares
10-Q · filed 2024-05-03
2023-12-312.75B shares
10-K · filed 2025-02-14
2023-09-302.75B shares
10-Q · filed 2023-10-31
2023-06-302.75B shares
10-Q · filed 2023-08-04
2023-03-312.75B shares
10-Q · filed 2023-04-28
2022-12-312.75B shares
10-K · filed 2024-02-14
2022-09-302.75B shares
10-Q · filed 2022-11-04
2022-06-302.75B shares
10-Q · filed 2022-08-05
2022-03-312.75B shares
10-Q · filed 2022-04-28
2021-12-312.75B shares
10-K · filed 2023-02-09
2021-09-302.75B shares
10-Q · filed 2021-11-03
2021-06-302.75B shares
10-Q · filed 2021-08-04
2021-03-312.75B shares
10-Q · filed 2021-04-28
2020-12-312.75B shares
10-K · filed 2022-02-16
2020-09-302.75B shares
10-Q · filed 2020-10-29
2020-06-302.75B shares
10-Q · filed 2020-07-29
2020-03-312.75B shares
10-Q · filed 2020-05-01
2019-12-312.75B shares
10-K · filed 2021-02-09
2019-09-302.75B shares
10-Q · filed 2019-10-30
2019-06-302.75B shares
10-Q · filed 2019-07-31
2019-03-312.75B shares
10-Q · filed 2019-05-01
2018-12-312.75B shares
10-K · filed 2020-02-12
2018-09-302.75B shares
10-Q · filed 2018-10-31
2018-06-302.75B shares
10-Q · filed 2018-07-27
2018-03-312.75B shares
10-Q · filed 2018-04-25
2017-12-312.75B shares
10-K · filed 2019-02-13
2017-09-302.75B shares
10-Q · filed 2017-10-26
2017-06-302.75B shares
10-Q · filed 2017-07-26
2017-03-312.75B shares
10-Q · filed 2017-04-27
2016-12-312.75B shares
10-K · filed 2018-02-13
2016-09-302.75B shares
10-Q · filed 2016-10-28
2016-06-302.75B shares
10-Q · filed 2016-07-29
2016-03-312.75B shares
10-Q · filed 2016-05-02
2015-12-312.75B shares
10-K · filed 2017-02-14
2015-09-302.75B shares
10-Q · filed 2015-11-02
2015-06-302.75B shares
10-Q · filed 2015-08-05
2015-03-312.75B shares
10-Q · filed 2015-04-27
2014-12-312.75B shares
8-K · filed 2016-10-31
2014-09-302.75B shares
10-Q · filed 2014-10-29
2014-06-302.75B shares
10-Q · filed 2014-08-05
2014-03-312.75B shares
10-Q · filed 2014-04-30
2013-12-312.75B shares
10-K · filed 2015-02-19
2013-09-302.75B shares
10-Q · filed 2013-10-29
2013-06-302.75B shares
10-Q · filed 2013-08-06
2013-03-312.75B shares
10-Q · filed 2013-05-03
2012-12-312.75B shares
10-K · filed 2014-02-24
2012-09-302.75B shares
10-Q · filed 2012-11-06
2012-06-302.75B shares
10-Q · filed 2012-08-08
2012-03-312.75B shares
10-Q · filed 2012-05-08
2011-12-312.75B shares
10-K · filed 2013-02-27
2011-09-302.75B shares
10-Q · filed 2011-11-04
2011-06-302.75B shares
10-Q · filed 2011-08-08
2011-03-312.75B shares
10-Q · filed 2011-05-10
2010-12-312.75B shares
10-K · filed 2012-02-29
2010-09-302.75B shares
10-Q · filed 2010-11-08
2010-06-302.75B shares
10-Q · filed 2010-08-09
2010-03-312.75B shares
10-Q · filed 2010-05-07
2009-12-312.75B shares
10-K · filed 2011-02-25
2009-09-302.75B shares
10-Q · filed 2009-11-06
2009-06-302.75B shares
10-Q · filed 2009-08-10
2008-12-312.75B shares
10-K · filed 2010-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
GILEAD SCIENCES, INC. (GILD)United States$185.522B-48.37
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31